2024 ESC Guidelines for the management of peripheral arterial and aortic diseases
The 2024 ESC guideline merges peripheral arterial and aortic disease into one document, treating the arterial tree as a single organ. It covers antithrombotic therapy in peripheral artery disease, revascularisation in chronic limb-threatening ischaemia, aneurysm thresholds and surveillance, type B dissection and carotid disease. The register's landmark trials are grouped by vascular bed below.
This guideline cites 13 of the 199 landmark trials in our Cardiology register.
Peripheral artery disease — antithrombotic therapy3
- 2020VOYAGER PADCardiology · Vascular · Antithrombotic therapyVascular Outcomes Study of ASA Along with Rivaroxaban in Endovascular or Surgical Limb Revascularization for PAD
- 2017EUCLIDCardiology · Vascular · Antithrombotic therapyExamining Use of Ticagrelor in Symptomatic Peripheral Artery Disease
- 2017COMPASSCardiology · Thrombosis · Chronic atherosclerosisCardiovascular Outcomes for People Using Anticoagulation Strategies
Chronic limb-threatening ischaemia — revascularisation2
Abdominal aortic aneurysm3
- 2016EVAR-1Cardiology · Vascular · Aortic aneurysmUK Endovascular Aneurysm Repair Trial 1 — 15-year follow-up
- 2014IMPROVECardiology · Vascular · Aortic aneurysmImmediate Management of the Patient with Rupture: Open Versus Endovascular Repair
- 1998UK Small Aneurysm TrialCardiology · Vascular · Aortic aneurysmUK Small Aneurysm Trial — early elective surgery versus ultrasonographic surveillance
Type B aortic dissection1
- 2013INSTEAD-XLCardiology · Vascular · Aortic dissectionInvestigation of Stent Grafts in Aortic Dissection — eXtended Long-term follow-up